newsfilter
← Latest News
GlobeNewswire·

Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel

HAIFA, Israel, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic...